Biohit Oyj Press Release December 22, 2014 at 3 pm. local time (EET)
Biohit Oyj and Eurobio have signed a distributor agreement regarding diagnostic tests of Biohit. The agreement is effective immediately, and Eurobio gains exclusive rights for the distribution of diagnostic tests in France, Morocco, Tunisia and Algeria. The agreement covers the following Biohit tests: GastroPanel®, Helicobacter Pylori UFT300 Quick Test, Biohit Active B12 vitamin test, ColonView Quick Test, Lactose Intolerance Quick Test and Celiac Disease Quick Test.
GastroPanel® is a non-invasive test for stomach health. The test diagnoses H. pylori infection and atrophic gastritis, caused by Helicobacter pylori infection or autoimmune disease. These results can be used to assess whether patients have risk of gastric and esophageal cancer, peptic ulcer disease or risk of vitamin B12-, calcium- and iron malabsorption and if eventual further examinations are needed (attachment: additional information).
Helicobacter Pylori UFT300 Quick Test is a true quick test for the detection of H. pylori from a biopsy specimen. Helicobacter Pylori UFT300 Quick Test has excellent sensitivity and specificity which makes it a highly accurate tool for H. pylori diagnostics.
Biohit Active B12 vitamin test measures the level of biologically active B12 vitamin from a blood sample. Vitamin B12 deficiency can occur in seemingly healthy people, and the risk increases with age. The test does not measure the level of total B12, but it measures the level of active form of vitamin B12, holotranscobalamin, available for the cells.
ColonView Quick Test is a diagnostic test for screening of colorectal cancer (CRC). This sensitive test detects fecal occult blood derived from both the upper and lower gastrointestinal tract - with improved sensitivity for even small benign lesions (polyps) and cancer precursors (adenomas).
The Lactose Intolerance Quick Test developed by Biohit for rapid diagnosis of lactose intolerance (hypolactasia of the small intestine) is based on the activity of the lactase enzyme in a duodenal biopsy specimen. Celiac Disease Quick Test measures gluten antibodies in serum and negative results exclude celiac disease. The test will bring clear benefits in healthcare costs, because it reduces the number of unnecessary endoscopies.
CEO Semi Korpela, Biohit Oyj: ’This is an outstanding opening for French speaking market area. Eurobio offers us a high-grade partnership with well-established market position on the chosen area.’
Managing Director and owner Denis Fortier, Eurobio: ‘We are very happy to sign this agreement with Biohit, and are looking forward to develop this business together. This new range of products will open new perspectives and challenges to our current catalogue and considerably develop our positioning in innovative markers.’
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Attachment: additional information
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com
Eurobio in brief
For almost fifty years, Eurobio has been present on in-vitro diagnostic and life science markets, which makes it a reknown society in the development, making and marketing of high-quality, innovative in-vitro diagnostic. Besides, this experience in diagnostic and life science products allows the company to develop and to offer complete solutions for laboratories and for biotechnology, research and pharmaceutical laboratories. Today, Eurobio has the ambition to stand as one of the greatest French innovative products distributors. Eurobio is one the leaders on the french in-vitro diagnostic market. The company is located at Les Ulis, northwest from Paris. www.eurobio.fr
